Evaluation of bioavailability of three types of IFNbeta in multiple sclerosis patients by a new quantitative-competitive-PCR method for MxA quantification. (Q43874500)

From Wikidata

Jump to navigation Jump to search

scientific article published in October 2001

Language	Label	Description	Also known as
English	Evaluation of bioavailability of three types of IFNbeta in multiple sclerosis patients by a new quantitative-competitive-PCR method for MxA quantification.	scientific article published in October 2001

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516761%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Evaluation of bioavailability of three types of IFNbeta in multiple sclerosis patients by a new quantitative-competitive-PCR method for MxA quantification (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516761%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

multiple sclerosis

0 references

bioavailability

1 reference

based on heuristic

inferred from title

Antonio Bertolotto

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516761%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Francesca Gilli

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516761%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

A Sala

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516761%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

L Audano

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516761%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A Castello

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516761%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

U Magliola

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516761%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

F Melis

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516761%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M T Giordana

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516761%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 October 2001

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516761%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Journal of Immunological Methods

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516761%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

256

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516761%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1-2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516761%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

141-152

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516761%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

cDNA structures and regulation of two interferon-induced human Mx proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900434-3

7 January 2021

Correlation of interferon-induced expression of MxA mRNA in peripheral blood mononuclear cells with the response of patients with chronic active hepatitis C to IFN-alpha therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900434-3

7 January 2021

Transforming growth factor beta1 (TGFbeta1) mRNA level correlates with magnetic resonance imaging disease activity in multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900434-3

7 January 2021

Interferon beta neutralizing antibodies in multiple sclerosis: neutralizing activity and cross-reactivity with three different preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900434-3

7 January 2021

Treatment strategies for early-stage chronic lymphocytic leukemia: can interferon-inducible MxA protein and tumor necrosis factor play a role as predictive markers for response to interferon therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900434-3

7 January 2021

A rapid and versatile method to synthesize internal standards for competitive PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900434-3

7 January 2021

The MxA protein levels in whole blood lysates of patients with various viral infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900434-3

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900434-3

7 January 2021

Mathematical considerations of competitive polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900434-3

7 January 2021

Bioavailability of interferon beta 1b in MS patients with and without neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900434-3

7 January 2021

A comparative study of the relative bioavailability of different interferon beta preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900434-3

7 January 2021

Expression of MxA protein in inflammatory dermatoses

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900434-3

7 January 2021

Expression of MxA protein in blood lymphocytes discriminates between viral and bacterial infections in febrile children

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900434-3

7 January 2021

Mx proteins in blood leukocytes for monitoring interferon beta-1b therapy in patients with MS

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900434-3

7 January 2021

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900434-3

7 January 2021

MxA overexpression reveals a common genetic link in four Fanconi anemia complementation groups

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900434-3

7 January 2021

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900434-3

7 January 2021

Quantitation of interferon-induced Mx protein in whole blood lysates by an immunochemiluminescent assay: elimination of protease activity of cell lysates in toto.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900434-3

7 January 2021

Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900434-3

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900434-3

7 January 2021

Quantitative PCR: theoretical considerations with practical implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900434-3

7 January 2021

MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900434-3

7 January 2021

Common variable immunodeficiency (CVID) and MxA-protein expression in blood leucocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900434-3

7 January 2021

The type I interferon system is locally activated in psoriatic lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900434-3

7 January 2021

A whole blood immunoassay for the interferon-inducible human Mx protein

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900434-3

7 January 2021

The human intracellular Mx-homologous protein is specifically induced by type I interferons.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900434-3

7 January 2021

Interferon beta in the treatment of multiple sclerosis: mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900434-3

7 January 2021

Comparative study of the pharmacodynamic and pharmacologic effects of Betaseron and AVONEX.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900434-3

7 January 2021

Immunohistochemistry using antibodies to alpha-interferon and its induced protein, MxA, in Alzheimer's and Parkinson's disease brain tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900434-3

7 January 2021

Identifiers

10.1016/S0022-1759(01)00434-3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516761%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516761%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43874500&oldid=2105512652"